Tag: Biotech
Biotech, Zoppas (ICE): exports of Made in Italy companies +45% compared to 2019
(Finance) – “Today the export of Made in Italy companies in the biotech sector is over 16 billion eurosup 45% compared to 2019. The first half of 2024 was also…
Threatened a few weeks ago, biotech Inventiva carries out one of the biggest fundraising rounds in France – L’Express
Good news for Inventiva: the Burgundian company has just obtained funding of 348 million euros on Monday October 14. “She also signs one of the largest fundraisings recorded by a…
Nuclear, defense, biotech… How Bercy protects our French gems from foreign takeovers – L’Express
The tone used illustrates the sensitivity of the matter. “What are you talking about? Biogaran is not for sale. So far we have only received expressions of interest. Nothing more.…
these rich biotech people who want to “kill death” – L’Express
Will we one day be able to live to be 100, or even 120, in excellent health? Scientists working on extending lifespan have in any case made important discoveries in…
BB Biotech, Intesa Sanpaolo cuts target price and confirms Hold
(Tiper Stock Exchange) – Intesa Sanpaolo has lowered to 46.1 euros per share (from 51.1 euros) the target price on BB Biotechinvestment company in the field of biotechnology and listed…
BB Biotech, 2nd quarter NAV down fractionally
(Tiper Stock Exchange) – The first half of 2023 has been disappointing so far for investors of biotechnology sector: Strong rotation out of the sector put pressure on equity prices.…
The company to follow: Genmab, the biotech that came from the cold
It must be admitted, European biotechnology companies do not dot the stock markets of the Old Continent as they abound on the Nasdaq. Which makes Genmab all the more deserving.…
PNRR, Graziano: an opportunity for biotech, but streamlined procedures
(Finance) – “The mission 6 of the PNRR makes over half a billion euros available to Italy for the biomedical research, a much richer loan than that obtained overall by…
The company to watch: Sartorius Stedim Biotech, at the heart of life sciences
The value of tomorrow is realized in partnership with Zonebourse.com Like Lonza, whose career we have already mentioned in these columns, SSB is a strategic subcontractor in the life sciences…
BB Biotech, Intesa Sanpaolo confirms Hold and increases TP
(Finance) – Intesa Sanpaolo he raised a 63.8 euros per share (from 54.2 euros) on target price on the title BB Biotechan investment company in the field of biotechnology and…